What is Proprio?
Proprio operates at the vanguard of medical technology, integrating sophisticated robotics, computer vision, machine learning, and immersive computing to augment human performance in surgical environments. The company's platform is designed to enhance the efficacy of surgical procedures by providing surgeons with real-time, high-fidelity data visualization and guidance. By bridging the gap between human expertise and machine intelligence, Proprio is effectively redefining the standards of care in operating rooms globally. Its market position is bolstered by a strategic focus on high-acuity healthcare applications, where precision and data-driven insights are paramount to improving patient outcomes and operational efficiency.
How much funding has Proprio raised?
Proprio has raised a total of $66M across 2 funding rounds:
Series A
$23M
Series B
$43M
Series A (2020): $23M with participation from Cota Capital, Alan Frazier, and BOLD Capital Partners
Series B (2023): $43M, investors not publicly disclosed
Key Investors in Proprio
Cota Capital
Cota Capital is an investment firm that focuses on early-stage technology companies addressing innovative challenges in the enterprise sector, combining financial investment with deep operational expertise.
Alan Frazier
A prominent investor and founder of East Seattle Partners and Frazier Healthcare Partners, focusing on long-term value creation in the healthcare and life sciences sectors.
BOLD Capital Partners
A venture capital firm that invests in high-growth companies leveraging exponential technologies to solve significant global challenges, particularly within the healthcare and technology domains.
What's next for Proprio?
With the recent capital injection, Proprio is well-positioned to accelerate its product development roadmap and expand its commercial footprint. The company is expected to prioritize the scaling of its immersive computing infrastructure, ensuring that its surgical navigation systems meet the rigorous demands of modern healthcare institutions. As Proprio transitions into this next phase of maturity, the focus will likely shift toward broader clinical adoption and the integration of its proprietary machine learning models into diverse surgical specialties. This strategic expansion will be critical in maintaining its competitive advantage as the healthcare sector increasingly adopts AI-driven surgical assistance tools.
See full Proprio company page
